A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer-Reference-Cited by-同舟云学术

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Published:2014-09-11 Issue:3 Volume:147 Page:579-588
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Jameson Gayle S.,Petricoin Emanuel F.,Sachdev Jasgit,Liotta Lance A.,Loesch David M.,Anthony Stephen P.,Chadha Manpreet K.,Wulfkuhle Julia D.,Gallagher Rosa I.,Reeder Kimberley A.,Pierobon Mariaelena,Fulk Monica R.,Cantafio Nina A.,Dunetz Bryant,Mikrut William D.,Von Hoff Daniel D.,Robert Nicholas J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-3117-1.pdf

Reference22 articles.

1. Armstrong DK (2002) Relapsed ovarian cancer: challenges and management strategies for a chronic disease. Oncologist 7(Suppl 5):20–28

2. Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka D, Coleman R, Lu K, Xiao L, Kurzrock R (2010) Phase I clinical trials in 85 patients with gynecologic cancer: the M.D. Anderson Cancer Center experience. Gynecol Oncol 117(3):467–472. doi: 10.1016/j.ygyno.2010.02.008

3. Janku F, Tsimberidou AM, Wang X, Hong DS, Naing A, Gong J, Garrido-Laguna I, Parsons HA, Zinner RG, Kurzrock R (2011) Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic. Oncologist 16(3):327–335. doi: 10.1634/theoncologist.2010-0308

4. Bailey CH, Jameson G, Sima C, Fleck S, White E, Von Hoff DD, Weiss GJ (2012) Progression-free survival decreases with each subsequent therapy in patients presenting for phase I clinical trials. J Cancer 3:7–13

5. http://www.cancer.gov/cancertopics/druginfo/breastcancer . Accessed Oct 2013

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative proteomic analysis of HER2 protein expression in PDAC tumors;Clinical Proteomics;2024-03-20

2. Mass spectrometry-based phosphoproteomics in clinical applications;TrAC Trends in Analytical Chemistry;2023-06

3. Immune Resistance Mechanisms and the Road to Personalized Immunotherapy;American Society of Clinical Oncology Educational Book;2023-06

4. AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers;npj Precision Oncology;2023-02-16

5. Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach;Cell Reports Methods;2022-08